Abstract:In the absence of appropriate medical care, exposure to organophosphorus nerve agents, such as VX, can lead to respiratory failure, and potentially death by asphyxiation. Despite the critical role of respiratory disturbances in organophosphorus-induced toxicity, the nature and underlying mechanisms of respiratory failure remain poorly understood. This study aimed to characterize respiratory alterations by determining their type and duration in mice exposed to a subcutaneous sublethal dose of VX. Respiratory ventilation in Swiss mice was monitored using dual-chamber plethysmography for up to 7 days post-exposure. Cholinesterase activity was assessed via spectrophotometry, and levels of inflammatory biomarkers were quantified using Luminex technology in blood and tissues involved in respiration (diaphragm, lung, and medulla oblongata). Additionally, a histological study was conducted on these tissues to ensure their structural integrity. Ventilatory alterations appeared 20-25 minutes after the injection of 0.9 LD50 VX and increased until the end of the recording, i.e., 40 minutes after intoxication. Concurrent with the occurrence of apnea, increased inspiratory and expiratory times resulted in a significant decrease in respiratory rate in exposed mice compared to controls. Ventilatory amplitude and, consequently, minute volume were reduced, while specific airway resistance significantly increased, indicating bronchoconstriction. These ventilatory effects persisted up to 24 or even 72 hours post-intoxication, resolving on the 7th day. They were correlated with a decrease in acetylcholinesterase activity in the diaphragm, which persisted for up to 72 hours, and with the triggering of an inflammatory reaction in the same tissue. No significant histologic lesions were observed in the examined tissues. The ventilatory alterations observed up to 72 hours post-VX exposure appear to result from a functional failure of the respiratory system rather than tissue damage. This comprehensive characterization contributes to a better understanding of the respiratory effects induced by VX exposure, which is crucial for developing specific medical countermeasures.

Pulmonary involvement in the acquired immunodeficiency syndrome.

The upper inflection point of the pressure-volume curve

Post-VX exposure treatment of rats with engineered phosphotriesterases

Revealing nitrogenous VX metabolites and the whole-molecule VX metabolism in the urine of guinea pigs

Synergy Between Experiments and Computations: A Green Channel for Revealing Metabolic Mechanism of Xenobiotics in Chemical Toxicology

Detoxification of V‐nerve agents assisted by a microperoxidase: new pathway revealed by the use of a relevant VX simulant

[Late recurrence of Wilms' tumor].

Carnosic acid attenuates acute ethanol-induced liver injury via a SIRT1/p66Shc-mediated mitochondrial pathway.

Determination of tissue distribution of VX and its metabolites EMPA and EA-2192 in various rat tissues by LC-ESI-MS/MS after phosphotriesterase treatment

Production, Characterization and Application of Monoclonal-Antibodies Against the Organophosphorus Nerve Agent-Vx

[Experimental therapeutic action of a new sulfonamide, 2-p-aminobenzene-sulfonamido-3-methoxypyrazine].

What Goes Wrong with Lon in Ageing?

Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations

Effects of the nerve agent VX on hiPSC-derived motor neurons

A simple and sensitive ultra‐high performance liquid chromatography tandem mass spectrometry method for the quantitative analysis of VX‐548 in monkey plasma: Method validation and application to pharmacokinetic study

Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants

Asymmetric biodegradation of the nerve agents Sarin and VX by human dUTPase: chemometrics, molecular docking and hybrid QM/MM calculations

How does organophosphorus chemical warfare agent exposure affect respiratory physiology in mice?

Discovery of Novel Non-Oxime Reactivators Showing In Vivo Antidotal Efficiency for Sarin Poisoned Mice

Concentration‐dependent effects of the nerve agents cyclosarin and VX on cytochrome P450 in a HepaRG cell‐based liver model

Arterial distensibility in Wegener's granulomatosis: a carotid-femoral pulse wave velocity study.